Sustaining immunity after immunization against encapsulated bacteria.

Infections by encapsulated bacteria are important causes of infant mortality worldwide. Over the last 20 years protein-polysaccharide conjugate vaccines have been developed to protect against the major invasive bacterial diseases of childhood, Streptococcus pneumoniae, Haemophilus influenzae type b...

Full description

Bibliographic Details
Main Authors: Blanchard-Rohner, G, Pollard, A
Format: Journal article
Language:English
Published: 2008
_version_ 1797084108123275264
author Blanchard-Rohner, G
Pollard, A
author_facet Blanchard-Rohner, G
Pollard, A
author_sort Blanchard-Rohner, G
collection OXFORD
description Infections by encapsulated bacteria are important causes of infant mortality worldwide. Over the last 20 years protein-polysaccharide conjugate vaccines have been developed to protect against the major invasive bacterial diseases of childhood, Streptococcus pneumoniae, Haemophilus influenzae type b (Hib) and Neisseria meningitidis. These vaccines are highly immunogenic and have resulted in a huge reduction in the diseases caused by these bacteria in the countries that have introduced them in their immunisation schedules. However, it has been reported that infant immunisation is associated with a relatively short duration of antibody levels and vaccine effectiveness, despite the demonstrable presence of booster responses to further vaccine dose. In contrast, at older ages, more sustained protection has been described with just a single dose of a conjugate vaccine. Understanding the generation of long-term immunity, by protein-polysaccharide conjugate vaccines, is essential to reduce infant mortality through the improvement of vaccine formulation and scheduling.
first_indexed 2024-03-07T01:50:48Z
format Journal article
id oxford-uuid:9a065588-cb65-4750-8cca-434158220fe4
institution University of Oxford
language English
last_indexed 2024-03-07T01:50:48Z
publishDate 2008
record_format dspace
spelling oxford-uuid:9a065588-cb65-4750-8cca-434158220fe42022-03-27T00:18:25ZSustaining immunity after immunization against encapsulated bacteria.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:9a065588-cb65-4750-8cca-434158220fe4EnglishSymplectic Elements at Oxford2008Blanchard-Rohner, GPollard, AInfections by encapsulated bacteria are important causes of infant mortality worldwide. Over the last 20 years protein-polysaccharide conjugate vaccines have been developed to protect against the major invasive bacterial diseases of childhood, Streptococcus pneumoniae, Haemophilus influenzae type b (Hib) and Neisseria meningitidis. These vaccines are highly immunogenic and have resulted in a huge reduction in the diseases caused by these bacteria in the countries that have introduced them in their immunisation schedules. However, it has been reported that infant immunisation is associated with a relatively short duration of antibody levels and vaccine effectiveness, despite the demonstrable presence of booster responses to further vaccine dose. In contrast, at older ages, more sustained protection has been described with just a single dose of a conjugate vaccine. Understanding the generation of long-term immunity, by protein-polysaccharide conjugate vaccines, is essential to reduce infant mortality through the improvement of vaccine formulation and scheduling.
spellingShingle Blanchard-Rohner, G
Pollard, A
Sustaining immunity after immunization against encapsulated bacteria.
title Sustaining immunity after immunization against encapsulated bacteria.
title_full Sustaining immunity after immunization against encapsulated bacteria.
title_fullStr Sustaining immunity after immunization against encapsulated bacteria.
title_full_unstemmed Sustaining immunity after immunization against encapsulated bacteria.
title_short Sustaining immunity after immunization against encapsulated bacteria.
title_sort sustaining immunity after immunization against encapsulated bacteria
work_keys_str_mv AT blanchardrohnerg sustainingimmunityafterimmunizationagainstencapsulatedbacteria
AT pollarda sustainingimmunityafterimmunizationagainstencapsulatedbacteria